Beam Therapeutics Inc. 10-K filing
Filed 2026-02-24 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-065194
- Form type
- 10-K
- CIK
- 0001745999
- Primary document
- https://www.sec.gov/Archives/edgar/data/1745999/000119312526065194/beam-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beam Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $139.7M | - | - |
| Operating Income | $-383.7M | - | - |
| Net Income | $-80.0M | - | - |
| Eps Basic | -0.81 | - | - |
| Eps Diluted | -0.81 | - | - |
| Cash And Equivalents | $294.9M | - | - |
| Total Assets | $1.5B | - | - |
| Total Liabilities | $242.8M | - | - |
| Shareholders Equity | $1.2B | - | - |
| Operating Cash Flow | $-345.1M | - | - |
| Capital Expenditures | $14.9M | - | - |